Raymond J. Henley Iii

Array ( [id] => 3740940 [patent_doc_number] => 05753659 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Heterocyclic compouds' [patent_app_type] => 1 [patent_app_number] => 8/458180 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89689 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753659.pdf [firstpage_image] =>[orig_patent_app_number] => 458180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3585989 [patent_doc_number] => 05585118 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Choline in the treatment of bipolar disorder' [patent_app_type] => 1 [patent_app_number] => 8/460060 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8517 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585118.pdf [firstpage_image] =>[orig_patent_app_number] => 460060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3691773 [patent_doc_number] => 05604210 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Inhibitor of vascular permeability enhancer' [patent_app_type] => 1 [patent_app_number] => 8/456723 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8528 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604210.pdf [firstpage_image] =>[orig_patent_app_number] => 456723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661690 [patent_doc_number] => 05624907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Beverage for preoperative intake' [patent_app_type] => 1 [patent_app_number] => 8/456951 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3165 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624907.pdf [firstpage_image] =>[orig_patent_app_number] => 456951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787758 [patent_doc_number] => 05736553 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo›4,5-C!quinolin-4-amine' [patent_app_type] => 1 [patent_app_number] => 8/471440 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9902 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736553.pdf [firstpage_image] =>[orig_patent_app_number] => 471440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3506674 [patent_doc_number] => 05562901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Method for the treatment of hemorrhoidal diseases' [patent_app_type] => 1 [patent_app_number] => 8/450465 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3839 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/562/05562901.pdf [firstpage_image] =>[orig_patent_app_number] => 450465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3546609 [patent_doc_number] => 05545569 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells' [patent_app_type] => 1 [patent_app_number] => 8/450520 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17870 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545569.pdf [firstpage_image] =>[orig_patent_app_number] => 450520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3518762 [patent_doc_number] => 05506248 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-09 [patent_title] => 'Pharmaceutical compositions having good dissolution properties' [patent_app_type] => 1 [patent_app_number] => 8/445623 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7045 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/506/05506248.pdf [firstpage_image] =>[orig_patent_app_number] => 445623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3967090 [patent_doc_number] => 05886023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Agent for improving dementia' [patent_app_type] => 1 [patent_app_number] => 8/447054 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2359 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886023.pdf [firstpage_image] =>[orig_patent_app_number] => 447054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590368 [patent_doc_number] => 05567692 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => '9-[(substituted glycyl) amido)]-6-demethyl-6-deoxytetracyclines' [patent_app_type] => 1 [patent_app_number] => 8/443612 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19401 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 2425 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567692.pdf [firstpage_image] =>[orig_patent_app_number] => 443612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3758108 [patent_doc_number] => 05721228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-24 [patent_title] => 'Rectal flunisolide compositions for treating inflammatory intestinal disorders' [patent_app_type] => 1 [patent_app_number] => 8/436291 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2347 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/721/05721228.pdf [firstpage_image] =>[orig_patent_app_number] => 436291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623832 [patent_doc_number] => 05602150 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia' [patent_app_type] => 1 [patent_app_number] => 8/440824 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 8723 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602150.pdf [firstpage_image] =>[orig_patent_app_number] => 440824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729004 [patent_doc_number] => 05670540 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Triglycerides of fatty acids' [patent_app_type] => 1 [patent_app_number] => 8/440987 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3809 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670540.pdf [firstpage_image] =>[orig_patent_app_number] => 440987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3609579 [patent_doc_number] => 05589510 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Method for inhibiting retroviral infection by administering a naphthalenesulfonic acid compound' [patent_app_type] => 1 [patent_app_number] => 8/441219 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6979 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589510.pdf [firstpage_image] =>[orig_patent_app_number] => 441219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648978 [patent_doc_number] => 05684050 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Stable emulsions of highly fluorinated organic compounds' [patent_app_type] => 1 [patent_app_number] => 8/441531 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3970 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/684/05684050.pdf [firstpage_image] =>[orig_patent_app_number] => 441531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591059 [patent_doc_number] => 05567733 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => 'Irritation relief using nonsteroidal anti-inflammatory compounds' [patent_app_type] => 1 [patent_app_number] => 8/429833 [patent_app_country] => US [patent_app_date] => 1995-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2466 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567733.pdf [firstpage_image] =>[orig_patent_app_number] => 429833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695663 [patent_doc_number] => 05618817 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders' [patent_app_type] => 1 [patent_app_number] => 8/428899 [patent_app_country] => US [patent_app_date] => 1995-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2285 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618817.pdf [firstpage_image] =>[orig_patent_app_number] => 428899 [rel_patent_id] =>[rel_patent_doc_number] =>)